The CollabRx Colorectal Targeted Therapy App, and our relationship with CAP (The College of American Pathologists) is briefly described in the latest issue of the British Journal of Healthcare Computing. The article quotes the chief editor of the app, Dr Heinz-Josef Lenz, professor at the Keck School of Medicine, University of Southern California: “The Therapy […]
CollabRx partners with The College of American Pathologists Partners to Provide Personalized Decision Tools to Cancer Patients
The College of American Pathologists (CAP) announced today its partnership with CollabRx to provide patients with advanced stage lung or skin cancer access to the cutting-edge information on cancer therapies that could change their lives. Patients can now download the CollabRx Targeted Therapy Finder apps through the College’s website, and their patient portal, MyBiopsy.org, to find the latest information on diagnostic tests, clinical trials, […]
A team including leading lung cancer researchers, and CollabRx scientists, has just published a novel Lung Cancer Molecular Disease Model in PLoS ONE, a leading peer-reviewed open source journal. (
February, 2012 — CollabRx’s Lung Cancer Targeted Therapy Finder and Dr. Ravi Salga, chief editor and advisor for the Lung Cancer Targeted Therapy Finder, are featured in an article published by the University of Chicago School of Medicine as part of their Comprehensive Cancer Center’s lung cancer program.